NO20021607L - Kationiske DOSPER-virosomer - Google Patents

Kationiske DOSPER-virosomer

Info

Publication number
NO20021607L
NO20021607L NO20021607A NO20021607A NO20021607L NO 20021607 L NO20021607 L NO 20021607L NO 20021607 A NO20021607 A NO 20021607A NO 20021607 A NO20021607 A NO 20021607A NO 20021607 L NO20021607 L NO 20021607L
Authority
NO
Norway
Prior art keywords
cationic
virosomes
lipids
virosome
relates
Prior art date
Application number
NO20021607A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021607D0 (no
Inventor
Ernst Rudolf Waelti
Reinhard Glueck
Peter Klein
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/414,872 external-priority patent/US6210708B1/en
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of NO20021607D0 publication Critical patent/NO20021607D0/no
Publication of NO20021607L publication Critical patent/NO20021607L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20021607A 1999-10-08 2002-04-05 Kationiske DOSPER-virosomer NO20021607L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/414,872 US6210708B1 (en) 1996-05-08 1999-10-08 Cationic virosomes as transfer system for genetic material
PCT/EP2000/009540 WO2001026628A1 (en) 1999-10-08 2000-09-29 Cationic dosper virosomes

Publications (2)

Publication Number Publication Date
NO20021607D0 NO20021607D0 (no) 2002-04-05
NO20021607L true NO20021607L (no) 2002-06-07

Family

ID=23643351

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021607A NO20021607L (no) 1999-10-08 2002-04-05 Kationiske DOSPER-virosomer

Country Status (19)

Country Link
EP (1) EP1217990B1 (da)
JP (1) JP2003512306A (da)
KR (1) KR100869195B1 (da)
AT (1) ATE258428T1 (da)
AU (1) AU778399B2 (da)
CA (1) CA2388053A1 (da)
CO (1) CO5280052A1 (da)
CZ (1) CZ20021216A3 (da)
DE (1) DE60008006T2 (da)
DK (1) DK1217990T3 (da)
ES (1) ES2215073T3 (da)
HU (1) HUP0202809A2 (da)
NO (1) NO20021607L (da)
PE (1) PE20010703A1 (da)
PL (1) PL355231A1 (da)
RU (1) RU2002112224A (da)
SK (1) SK4782002A3 (da)
TR (1) TR200200930T2 (da)
WO (1) WO2001026628A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA008497B1 (ru) * 2002-11-21 2007-06-29 Певион Биотех Лтд. Высокоэффективные способные к слиянию везикулы, способ их получения и фармацевтическая композиция, их содержащая
JP4497894B2 (ja) * 2003-11-07 2010-07-07 明彦 河合 物質導入剤およびその製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL296382A1 (en) * 1991-02-02 1993-11-02 Nika Health Products Ltd Li Li Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system
DE19521412A1 (de) * 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung
HUP9901790A3 (en) * 1996-05-08 2010-11-29 Nika Health Products Ltd Cationic virosomes as transfer system for genetic material
ATE340259T1 (de) * 1996-07-16 2006-10-15 Archibald James Mixson Kationisches vehikel: dns komplexe und ihre verwendung in gentherapie

Also Published As

Publication number Publication date
ES2215073T3 (es) 2004-10-01
NO20021607D0 (no) 2002-04-05
ATE258428T1 (de) 2004-02-15
RU2002112224A (ru) 2004-01-10
HUP0202809A2 (hu) 2002-12-28
KR20020063872A (ko) 2002-08-05
EP1217990A1 (en) 2002-07-03
TR200200930T2 (tr) 2002-08-21
SK4782002A3 (en) 2002-09-10
AU7785000A (en) 2001-04-23
WO2001026628A1 (en) 2001-04-19
AU778399B2 (en) 2004-12-02
DE60008006D1 (de) 2004-03-04
DK1217990T3 (da) 2004-05-24
KR100869195B1 (ko) 2008-11-18
EP1217990B1 (en) 2004-01-28
PL355231A1 (en) 2004-04-05
DE60008006T2 (de) 2004-09-09
CZ20021216A3 (cs) 2002-10-16
PE20010703A1 (es) 2001-07-11
CA2388053A1 (en) 2001-04-19
JP2003512306A (ja) 2003-04-02
CO5280052A1 (es) 2003-05-30

Similar Documents

Publication Publication Date Title
Ruponen et al. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies
KR101168440B1 (ko) 지질 캡슐화된 간섭 rna
US20230212578A1 (en) Compositions and methods for treating hypertriglyceridemia
CN101346393B (zh) 修饰的siRNA分子及其应用
Pupo et al. Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization–extrusion technique
CA2506593A1 (en) High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them
WO2007031333A3 (en) Improvements in or relating to amphoteric liposomes
EP2335687B1 (en) Use of monoolein as a new auxiliary lipid in lipofection
AU5161800A (en) Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
Sen et al. Design, syntheses, and transfection biology of novel non-cholesterol-based guanidinylated cationic lipids
NZ332666A (en) Cationic virosomes having a positively charged lipid bilayer membrane with an integrated viral fusogenic peptide as genetic transfer systems for use in gene therapy
EP1764089A1 (en) Serum stable liposomes comprising amphoter II lipid mixtures
CN102481256A (zh) 包含亚氨基脂质的两性脂质体
Karmali et al. In vitro gene transfer efficacies and serum compatibility profiles of novel mono-, di-, and tri-histidinylated cationic transfection lipids: a structure− activity investigation
Hope Enhancing siRNA delivery by employing lipid nanoparticles
AU2001254548B2 (en) Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane
CN1915968A (zh) 用于核酸及药物传递的中性-阳离子类脂
WO2003057164A3 (en) Compounds for delivering substances into cells
WO2005067632A3 (en) Lipid compositions and use thereof
WO2003102150A3 (en) Multi-functional polyamines for delivery of biologically-active polynucleotides
DK1217990T3 (da) Kationiske DOSPER-virosomer
DK2140870T3 (da) Bærestofsammensætning til øjeblikkelig nukleinsyrefremføring
Sen et al. Gene transfer efficacies of novel cationic amphiphiles with alanine, β-alanine, and serine headgroups: a structure− activity investigation
Dewa et al. Novel Polyamine− Dialkyl Phosphate Conjugates for Gene Carriers. Facile Synthetic Route via an Unprecedented Dialkyl Phosphate
WO2001042424A3 (en) Sphingolipid-containing cationic liposomes for topical delivery of bioactive material

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application